Sarcoma
Showing NaN - NaN of 74
Molecular Testing for MD Anderson Cancer Center Personalized
Recruiting
- Glioma
- +4 more
- Biospecimen Collection
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jan 20, 2023
Ovarian Cancer, Cervical Cancer, Endometrial Cancer Trial in Worldwide (Enapotamab vedotin (HuMax-AXL-ADC))
Completed
- Ovarian Cancer
- +7 more
- Enapotamab vedotin (HuMax-AXL-ADC)
-
Phoenix, Arizona
- +40 more
Dec 12, 2022
Sarcoma Trial in Houston (Autologous HER2-specific T cells, Fludarabine, Cyclophosphamide)
Active, not recruiting
- Sarcoma
- Autologous HER2-specific T cells
- +3 more
-
Houston, Texas
- +1 more
Nov 21, 2022
Prostate Cancer, Bladder Cancer, NSCLC Trial in New York, Houston (NY-ESO-1 Plasmid DNA Cancer Vaccine)
Completed
- Prostate Cancer
- +4 more
- NY-ESO-1 Plasmid DNA Cancer Vaccine
-
New York, New York
- +1 more
Oct 3, 2022
Malignant Digestive System Tumor, Metastatic Head and Neck Carcinoma, Metastatic Kidney Carcinoma Trial in Houston (procedure,
Recruiting
- Malignant Digestive System Neoplasm
- +12 more
- Computed Tomography
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Sep 22, 2022
Breast Cancer, Head Neck Cancer, Squamous Cell Carcinoma Trial in Canada, United States (INT230-6, anti-PD-1 antibody,
Active, not recruiting
- Breast Cancer
- +10 more
- INT230-6
- +2 more
-
Los Angeles, California
- +7 more
Jun 21, 2022
Sarcoma Trial in Houston (Best Practice, Informational Intervention, Questionnaire Administration)
Recruiting
- Sarcoma
- Best Practice
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jan 18, 2022
Sarcoma, HER-2 Protein Overexpression Trial in Houston (cells, Pembrolizumab Injectable Product, Nivolumab Injectable Product)
Recruiting
- Sarcoma
- HER-2 Protein Overexpression
- cells
- +3 more
-
Houston, TexasTexas Children's Hospital
Dec 8, 2021
Advanced Solid Tumors, Carcinoid, Colorectal Cancer Trial in Poland, Spain, United States (Modified FOLFOX6, Conatumumab,
Completed
- Advanced Solid Tumors
- +8 more
- Modified FOLFOX6
- +3 more
-
Duarte, California
- +11 more
Feb 3, 2021
Sarcoma Trial in Houston (Ra-223 Dichloride)
Completed
- Sarcoma
- Ra-223 Dichloride
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 13, 2021
Detecting Anal and Genital Human Papillomavirus Infection and
Completed
- Aids-related Malignancies
- +3 more
- polymerase chain reaction
- +3 more
-
La Jolla, California
- +9 more
Aug 7, 2020
Sarcoma, Melanoma, NSCLC Trial in United States (CMB305, G100, Metronomic CPA)
Terminated
- Sarcoma
- +3 more
- CMB305
- +2 more
-
Santa Monica, California
- +7 more
Jun 29, 2020
Synovial Sarcoma, Cancer, Soft Tissue Sarcoma Trial in Canada, United States (LV305, G305, LV305-matching )
Terminated
- Synovial Sarcoma
- +4 more
- LV305
- +3 more
-
Scottsdale, Arizona
- +28 more
Apr 3, 2020
Sarcoma Trial in United States (Gemcitabine and Pazopanib, Gemcitabine and Docetaxel)
Completed
- Sarcoma
- Gemcitabine and Pazopanib
- Gemcitabine and Docetaxel
-
Tucson, Arizona
- +7 more
Mar 23, 2020
Colorectal Cancer, Triple Negative Breast Cancer, Pancreatic Cancer Trial in Denver, Miami, Houston (Toca 511, Toca FC)
Terminated
- Colorectal Cancer
- +11 more
- Toca 511
- Toca FC
-
Denver, Colorado
- +2 more
Feb 5, 2020
Advanced Cancers, Sarcoma Trial in Houston (Hyperthermic Peritoneal Perfusion (HIPEC), Cisplatin)
Completed
- Advanced Cancers
- Sarcoma
- Hyperthermic Peritoneal Perfusion (HIPEC)
- Cisplatin
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 8, 2020